国泰中证生物医药ETF联接C(006757)份额变动
截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
2025-03-30 |
494,769,149.10 |
468,793,130.27 |
91,714,539.68 |
117,690,558.51 |
2024-12-30 |
513,309,868.90 |
494,769,149.10 |
169,403,240.09 |
187,943,959.89 |
2024-09-29 |
525,720,219.17 |
513,309,868.90 |
78,805,206.42 |
91,215,556.69 |
2024-06-29 |
512,857,834.18 |
525,720,219.17 |
109,081,310.89 |
96,218,925.90 |
2024-03-30 |
515,917,151.56 |
512,857,834.18 |
121,956,539.27 |
125,015,856.65 |
2023-12-30 |
530,090,389.25 |
515,917,151.56 |
105,450,844.67 |
119,624,082.36 |
2023-09-29 |
524,715,503.63 |
530,090,389.25 |
114,355,823.12 |
108,980,937.50 |
2023-06-29 |
473,016,606.54 |
524,715,503.63 |
164,450,758.31 |
112,751,861.22 |
2023-03-30 |
487,345,564.83 |
473,016,606.54 |
105,644,830.70 |
119,973,788.99 |
2022-12-30 |
588,121,147.27 |
487,345,564.83 |
184,110,365.94 |
284,885,948.38 |
2022-09-29 |
437,578,383.80 |
588,121,147.27 |
351,515,188.71 |
200,972,425.24 |
2022-06-29 |
416,032,220.56 |
437,578,383.80 |
155,433,233.75 |
133,887,070.51 |
2022-03-30 |
416,918,546.35 |
416,032,220.56 |
183,448,687.34 |
184,335,013.13 |